贝那普利联合阿托伐他汀钙片治疗高血压合并冠心病的临床疗效

The Clinical Curative Effect of Benazepril Symphysis Atorvastatin Calcium in Treatment Hypertension Combined Coronary Heart Disease(CHD)

目的评价贝那普利联合应用阿托伐他汀钙片治疗高血压合并冠心病患者的临床疗效。方法将我院2013年10月-2015年10月收治的168例高血压合并冠心病患者作为本次的研究对象,分为对照组和治疗组,每组84例,对照组应用贝那普利进行治疗,治疗组在此基础上联合应用阿伐他汀钙片进行治疗。结果治疗组心绞痛发生率与心肌梗死发生率分均低于对照组,差异均有统计学意义（P〈0.05）。结论贝那普利联合阿托伐他汀钙片治疗高血压合并冠心病患者可以取得临床疗效,患者治疗期间心绞痛发生率和心肌梗死发生率均降低。

Objective Evaluation that benazepril combined use of atorvastatin calcium treatment hypertension combined clinical curative effect in patients with coronary heart disease. Methods From October 2013 to October 2015,168 cases of hypertension with coronary heart disease patients as the research object,is divided into control group and treatment group,84 cases in each group,the control application that benazepril treatment,treatment group on the basis of the combined use of atonrastatin statin calcium treatment. Results Incidence of angina pectoris and myocardial infarction,the incidence of treatment group were significantly lower than the control group,the differences were statistically significant（P〈0.05）. Conclusion That split joint atorvastatin calcium tablets in the treatment of hypertension with coronary heart disease patients can achieve significant curative effect,during the treatment of patients with angina pectoris incidence and the incidence of myocardial infarction were significantly reduced.